Bupropion and Weight Control for Smoking Cessation - 1

Completed · Phase 4 · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.

Key facts

Study ID

NCT00006170

Run by

University of Pittsburgh

People needed

349

Starts

2000-09-01

Expected to finish

2010-09-01

Last updated by the study team

2016-07-21

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Smoke at least 10 cigarettes per day
• Report concern about cessation-related weight gain
• Motivated to quit smoking

You may not qualify if…

• Currently pregnant, lactating, or no medically approved method of contraception
• Major medical problem
• History of seizure disorder or head injury
• Current or historical psychosis or bipolar disorder
• History of alcohol or substance abuse within previous year
• Current or historical eating disorder
• Use of antidepressant medication, monoamine oxidase inhibitor or lithium with previous month
• Multiple Drug Allergies
• Current major depressive disorder

Where it is running

• Western Psychiatric Institute & Clinic — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.